Caitong International Asset Management Co., LTD Biotechnology

Caitong International Asset Management Co., LTD

$102 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
HALO Halozyme Therapeutics, Inc.	$8.06B	$8.46 Million 0.01% of portfolio	177	Q4 2024 New
QURE Uni Qure N.V.	$663M	$8.39 Million 0.01% of portfolio	475	Q4 2024 New
ARVN Arvinas, Inc.	$992M	$8.38 Million 0.01% of portfolio	437	Q4 2024 New
HUMA Humacyte, Inc.	$403M	$7.62 Million 0.01% of portfolio	1,508	Q4 2024 New
MRUS Merus N.V.	$1.84B	$7.15 Million 0.01% of portfolio	170	Q4 2024 New
CRDF Cardiff Oncology, Inc.	$186M	$5.84 Million 0.01% of portfolio	1,346	Q4 2024 New
TECH Bio Techne Corp	$2.56B	$4.97 Million 0.0% of portfolio	69	Q4 2024 New
SGMO Sangamo Therapeutics, Inc	$183M	$4.81 Million 0.0% of portfolio	4,714	Q4 2024 New
INSM Insmed Inc	$11B	$4.7 Million 0.0% of portfolio	68	Q4 2024 New
ALNY Alnylam Pharmaceuticals, Inc.	$30.8B	$3.77 Million 0.0% of portfolio	16	Q4 2024 New
QSI Quantum Si Inc	$233M	$3.32 Million 0.0% of portfolio	1,228	Q4 2024 New
FOLD Amicus Therapeutics, Inc.	$2.76B	$3.31 Million 0.0% of portfolio	351	Q4 2024 New
CADL Candel Therapeutics, Inc.	$282M	$2.87 Million 0.0% of portfolio	331	Q4 2024 New
AUTL Autolus Therapeutics PLC	$185M	$2.75 Million 0.0% of portfolio	1,172	Q4 2024 New
ABSI Absci Corp	$540M	$2.37 Million 0.0% of portfolio	904	Q4 2024 New
BCYC Bicycle Therapeutics PLC	$372M	$2.07 Million 0.0% of portfolio	148	Q4 2024 New
RXRX Recursion Pharmaceuticals, Inc.	$1.9B	$1.79 Million 0.0% of portfolio	264	Q4 2024 New
CAPR Capricor Therapeutics, Inc.	$392M	$1.7 Million 0.0% of portfolio	123	Q4 2024 New
AVIR Atea Pharmaceuticals, Inc.	$262M	$1.61 Million 0.0% of portfolio	479	Q4 2024 New
PRTA Prothena Corp Public LTD CO	$653M	$1.59 Million 0.0% of portfolio	115	Q4 2024 New
OLMA Olema Pharmaceuticals, Inc.	$201M	$1.48 Million 0.0% of portfolio	254	Q4 2024 New
PHAT Phathom Pharmaceuticals, Inc.	$226M	$1.45 Million 0.0% of portfolio	179	Q4 2024 New
SANA Sana Biotechnology, Inc.	$601M	$1.37 Million 0.0% of portfolio	843	Q4 2024 New
KALV Kal Vista Pharmaceuticals, Inc.	$240M	$1.33 Million 0.0% of portfolio	157	Q4 2024 New
INZY Inozyme Pharma, Inc.	$55M	$1.18 Million 0.0% of portfolio	425	Q4 2024 New
IMNM Immunome Inc.	$129M	$1.13 Million 0.0% of portfolio	106	Q4 2024 New
MREO Mereo Biopharma Group PLC	$366M	$1.12 Million 0.0% of portfolio	320	Q4 2024 New
CDXS Codexis, Inc.	$282M	$1.12 Million 0.0% of portfolio	234	Q4 2024 New
ANNX Annexon, Inc.	$145M	$1.08 Million 0.0% of portfolio	211	Q4 2024 New
IGMS Igm Biosciences, Inc.	$41.4M	$1.03 Million 0.0% of portfolio	169	Q4 2024 New
HRTX Heron Therapeutics, Inc.	$211M	$964,000 0.0% of portfolio	630	Q4 2024 New
SCPH Sc Pharmaceuticals Inc.	$99.5M	$945,000 0.0% of portfolio	267	Q4 2024 New
ALLK Allakos Inc.	$26.3M	$912,000 0.0% of portfolio	754	Q4 2024 New
ENTA Enanta Pharmaceuticals Inc	$148M	$874,000 0.0% of portfolio	152	Q4 2024 New
VTYX Ventyx Biosciences, Inc.	$96.7M	$867,000 0.0% of portfolio	396	Q4 2024 New
NKTX Nkarta, Inc.	$108M	$822,000 0.0% of portfolio	330	Q4 2024 New
BGNE Bei Gene, Ltd.	$23.5B	$739,000 0.0% of portfolio	4	Q4 2024 New
PSTX Poseida Therapeutics, Inc.	$815M	$720,000 0.0% of portfolio	75	Q4 2024 New
FULC Fulcrum Therapeutics, Inc.	$192M	$682,000 0.0% of portfolio	145	Q4 2024 New
STOK Stoke Therapeutics, Inc.	$421M	$651,000 0.0% of portfolio	59	Q4 2024 New
STRO Sutro Biopharma, Inc.	$93.4M	$644,000 0.0% of portfolio	350	Q4 2024 New
XERS Xeris Biopharma Holdings, Inc.	$488M	$631,000 0.0% of portfolio	186	Q4 2024 New
NVO Novo Nordisk A S	$186B	$516,000 0.0% of portfolio	6	Q4 2024 New
ATAI Atai Life Sciences N.V.	$382M	$513,000 0.0% of portfolio	386	Q4 2024 New
PYXS Pyxis Oncology, Inc.	$47.7M	$510,000 0.0% of portfolio	327	Q4 2024 New
RGNX Regenxbio Inc.	$316M	$502,000 0.0% of portfolio	65	Q4 2024 New
ATXS Astria Therapeutics, Inc.	$108M	$492,000 0.0% of portfolio	55	Q4 2024 New
ETNB 89bio, Inc.	$509M	$477,000 0.0% of portfolio	61	Q4 2024 New
ARCT Arcturus Therapeutics Holdings Inc.	$480M	$475,000 0.0% of portfolio	28	Q4 2024 New
PBYI Puma Biotechnology, Inc.	$130M	$406,000 0.0% of portfolio	133	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caitong International Asset Management Co., LTD, based on Form 13F filings with the SEC.

News

Stay updated on Caitong International Asset Management Co., LTD with notifications on news.